therapeutic 2,481 words KG: ent-dise-bfd8f32d 2026-03-24
kind:therapeuticsection:therapeuticsstate:publishedcbs-psp
Contents

Section 101: Microbiome-Gut-Brain Axis in CBS/PSP

💊 Therapeutic Info
NameSection 101: Microbiome-Gut-Brain Axis in CBS/PSP
SummaryComprehensive coverage of the gut-brain axis and microbiome alterations in corticobasal syndrome and progressive supranuclear palsy, including dysbiosis, SCFA production, leaky gut, bacterial metabolites, alpha-synuclein spreading, and therapeutic interventions

Knowledge Graph

Related Hypotheses (22)

TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Hippocampal CA3-CA1 circuit rescue via neurogenesis and syna
Score: 0.68
Vagal Afferent Microbial Signal Modulation
Score: 0.52
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
VCP-Mediated Autophagy Enhancement
Score: 0.41

Related Analyses (24)

4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
Do tau strains or regional cellular environments primarily d
neurodegeneration · failed
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · completed
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived

Related Experiments (17)

4R-Tau Targeting Therapies for PSP and CBS
clinical · proposed · Score: 0.40
Anti-Tau Therapy Failure Mechanism in PSP — Why Clinical Tri
clinical · proposed · Score: 0.40
Brainstem Circuit Modulation for PSP
clinical · proposed · Score: 0.40
CBS vs PSP Phenotype Determinants — Single-Nucleus Multi-Omi
validation · proposed · Score: 0.40
Levodopa Response Determinants in PSP — Biomarker-Guided Pre
clinical · proposed · Score: 0.40